Humanigen Hits Ch. 11 After COVID Drug Denied Authorization
By Ben Zigterman · January 4, 2024, 7:34 PM EST
After failing to receive emergency authorization for a COVID-19 treatment, drug developer Humanigen Inc. filed for Chapter 11 bankruptcy in Delaware with $44.1 million in unsecured debt and plans to pursue...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login